Vimarsana
Biggest News Aggregation in the World

Page 2 - Stephen Yoder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Yoder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Yoder Today - Breaking & Trending Today

Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ... - Vimarsana News

Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ...

Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase ...

Pieris Pharma Shares Halted as Partner Discontinues Asthma Treatment Trial - Vimarsana News

Pieris Pharma Shares Halted as Partner Discontinues Asthma Treatment Trial

By Adriano Marchese Pieris Pharmaceuticals shares were halted in premarket trading after its partner AstraZeneca decided to discontinue and cease dosing in...

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference - Vimarsana News

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference

BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology

Stock Market | FinancialContent Business Page - Vimarsana News

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript - Vimarsana News

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call.